When we think about immune disorders, names like lupus or HIV come to mind. But there's one rare, often overlooked condition that has quietly become a critical focus in immunology and biotech labs around the world — Chronic Granulomatous Disease (CGD). And now, this life-threatening illness is fueling a new wave of medical breakthroughs, pushing the boundaries of gene therapy, immunology,...